TimesSquare Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-840,269
Closed -$70.2M 163
2024
Q4
$70.2M Buy
840,269
+402,186
+92% +$33.6M 1.02% 32
2024
Q3
$32.1M Buy
438,083
+26,600
+6% +$1.95M 0.48% 84
2024
Q2
$28.2M Buy
411,483
+28,272
+7% +$1.94M 0.44% 90
2024
Q1
$26.5M Sell
383,211
-113,139
-23% -$7.83M 0.39% 100
2023
Q4
$35.5M Sell
496,350
-5,275
-1% -$378K 0.52% 83
2023
Q3
$26.1M Buy
501,625
+48,250
+11% +$2.51M 0.41% 100
2023
Q2
$28.7M Sell
453,375
-57,700
-11% -$3.65M 0.41% 105
2023
Q1
$27.7M Sell
511,075
-196,925
-28% -$10.7M 0.4% 108
2022
Q4
$37.5M Sell
708,000
-177,510
-20% -$9.39M 0.53% 90
2022
Q3
$41.2M Buy
885,510
+84,672
+11% +$3.94M 0.57% 78
2022
Q2
$45.7M Sell
800,838
-76,190
-9% -$4.35M 0.64% 64
2022
Q1
$53.7M Sell
877,028
-466,937
-35% -$28.6M 0.6% 72
2021
Q4
$70.3M Sell
1,343,965
-374,700
-22% -$19.6M 0.62% 63
2021
Q3
$64.1M Buy
1,718,665
+565,285
+49% +$21.1M 0.56% 70
2021
Q2
$47.1M Sell
1,153,380
-73,900
-6% -$3.02M 0.39% 112
2021
Q1
$41.6M Buy
1,227,280
+338,080
+38% +$11.5M 0.36% 124
2020
Q4
$28.3M Sell
889,200
-13,300
-1% -$423K 0.23% 158
2020
Q3
$23.2M Buy
+902,500
New +$23.2M 0.22% 167
2017
Q1
Sell
-1,534,938
Closed -$23.2M 263
2016
Q4
$23.2M Sell
1,534,938
-221,637
-13% -$3.34M 0.16% 202
2016
Q3
$26.8M Buy
1,756,575
+136,700
+8% +$2.08M 0.17% 194
2016
Q2
$62.9M Buy
1,619,875
+95,500
+6% +$3.71M 0.42% 97
2016
Q1
$42.4M Buy
1,524,375
+205,955
+16% +$5.73M 0.28% 135
2015
Q4
$70.9M Buy
1,318,420
+218,420
+20% +$11.7M 0.45% 86
2015
Q3
$44M Buy
+1,100,000
New +$44M 0.28% 136